Deal snapshot: IVF BIOSCIENCE ACQUIRES INTELLECTUAL PROPERTY FROM EMBRYOTRANS BIOTECH.
UK-based in-vitro fertilisation specialist IVF Bioscience has acquired EmbryoTrans Biotech's intellectual property for the production of IVF media for animal species used during the in-vitro fertilisation process. The transaction value has not been disclosed, the company said.
IVF Bioscience will launch their first species specific media with the Bovine BO-IVF range. EmbryoTrans Biotech will continue to develop new products for IVF Bioscience under an exclusive agreement.
Target: EmbryoTrans Biotech intellectual property for the production of IVF media
Buyer: IVF Bioscience
Vendor: EmbryoTrans Biotech
Deal size in USD:
Type: Corporate Acquisition
Buyer advisor: , ,
Comment: Terms of the deal were not disclosed
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Sep 23, 2015|
|Previous Article:||Deal snapshot: MOZIDO CLOSES ACQUISITION OF MOBILE COMMERCE FIRM CORFIRE.|
|Next Article:||Deal snapshot: CENTENE FILES DEFINITIVE PROXY STATEMENT/PROSPECTUS, SETS DATE FOR SPECIAL MEETING.|